<DOC>
	<DOCNO>NCT01068535</DOCNO>
	<brief_summary>The purpose study compare vascular permeability blood vessel wall ( carotid artery ) pre-menopausal woman metabolic syndrome ( syndrome least 3/5 follow features- increase abdominal fat , low good cholesterol ( HDL-C ) , elevate fast blood fat ( triglyceride ) , elevate blood pressure , elevate fast glucose ) versus woman normal weight normal cholesterol , blood fat , blood pressure , blood sugar . We use novel technology measure vascular permeability know dynamic contrast enhancement magnetic resonance imaging ( DCE-MRI ) . The primary variable ktrans ratio mathematically derive quantity obtain DCE-MRI . We try identify novel marker early atherosclerosis young woman .</brief_summary>
	<brief_title>Early Vascular Wall Changes Magnetic Resonance Imaging ( MRI ) Metabolic Syndrome Versus Metabolically Normal Pre-Menopausal Women : A Pilot Study</brief_title>
	<detailed_description>This study involve phone screen &amp; 2 study visit : - Screening visit , include quick finger stick cholesterol , glucose , triglycerides test ( cholestech ) determine qualification , waist measurement , weight . Results provide regardless qualification . If volunteer qualifies , full blood draw ( approximately 45cc 3 Tablespoons ) occur . A snack provide blood drawn . Additional study visit procedure include medical history questionnaire include menstrual history , height &amp; weight measurement , vital sign , waist &amp; hip measurement . This study last 90 minute . - MRI visit ( occur within week screen visit ) occur serum pregnancy &amp; creatinine result receive &amp; approve continue P.I . ( e.g . negative serum pregnancy eGFR &gt; 60 ) . An IV catheter place antecubital vein administer injection ( gadolinium ) contrast medium . A coil place side subject 's neck lay flat bench , upper body inside MRI scanner . The entire MRI procedure take approximately 60 minute .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Premenopausal woman ( age 3550 ) still menstrual period History diabetes mellitus History cardiovascular disease ( peripheral vascular disease , coronary artery disease , cerebrovascular disease ) Serum creatinine &gt; 1.2 mg/dL ( eGFR &lt; 60 ml/min . ) Active rheumatologic disease Use hormonal contraception* Pregnant planning pregnancy within next 3 month Fasting triglyceride ≥ 500 mg/dL Fasting LDLC ≥ 190 mg/dL Currently take lipid lower medications* Currently take vasoactive ( blood pressure ) medications* Hypertension : SBP ≥ 140 DBP ≥90 mm Hg Chronic use aspirin ( prn use allow ) Chronic use nonsteroidal antiinflammatory medication ( prn use allow ) Tobacco use within 3 month start study Participation another clinical trial within last 30 day MRI specific exclusion criterion : History claustrophobia History decrease kidney function ( eGFR &lt; 60 ml/min . ) History reaction contrast medium dye use MRI , CT Scan , Xray History significant anemia blood disease History seizures MRIincompatible metal internal metal hardware device * Drugs within follow classification exclusionary : Antilipemics , antilipidemics , beta blocker , ACE inhibitor , angiotensin receptor blocker , diuretic , calcium channel blocker , alpha blocker , nitrate , hormonal contraceptive</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>MetS</keyword>
	<keyword>premenopausal woman</keyword>
	<keyword>vascular risk</keyword>
	<keyword>atherosclerosis detection</keyword>
</DOC>